The non-receptor tyrosine phosphatase type 14 blocks caveolin-1-enhanced cancer cell metastasis
Natalia I Díaz-Valdivia1, Jorge Díaz1,2, Pamela Contreras1
1Cellular Communication Laboratory, Center for studies on Exercise, Metabolism and Cancer (CEMC), Advanced Center for Chronic Diseases (ACCDiS), Faculty of Medicine, Universidad de Chile, Santiago, Chile.
Abstract:
Caveolin-1 (CAV1) enhanced migration, invasion, and metastasis of cancer cells is inhibited by co-expression of the glycoprotein E-cadherin. Although the two proteins form a multiprotein complex that includes β-catenin, it remained unclear how this would contribute to blocking the metastasis promoting function of CAV1. Here, we characterized by mass spectrometry the protein composition of CAV1 immunoprecipitates from B16F10 murine melanoma cells expressing or not E-cadherin. The novel protein tyrosine phosphatase PTPN14 was identified by mass spectrometry analysis exclusively in co-immunoprecipitates of CAV1 with E-cadherin. Interestingly, PTPN14 is implicated in controlling metastasis, but only few known PTPN14 substrates exist. We corroborated by western blotting experiments that PTPN14 and CAV1 co-inmunoprecipitated in the presence of E-cadherin in B16F10 melanoma and other cancer cells. Moreover, the CAV1(Y14F) mutant protein was shown to co-immunoprecipitate with PTPN14 even in the absence of E-cadherin, and overexpression of PTPN14 reduced CAV1 phosphorylation on tyrosine-14, as well as suppressed CAV1-enhanced cell migration, invasion and Rac-1 activation in B16F10, metastatic colon [HT29(US)] and breast cancer (MDA-MB-231) cell lines. Finally, PTPN14 overexpression in B16F10 cells reduced the ability of CAV1 to induce metastasis in vivo. In summary, we identify here CAV1 as a novel substrate for PTPN14 and show that overexpression of this phosphatase suffices to reduce CAV1-induced metastasis.
Insights
The protein tyrosine phosphatase PTPN14 dephosphorylates caveolin-1 (CAV1), inhibiting cancer cell migration and metastasis. Overexpressing PTPN14 reduces CAV1
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Caveolin-1 (CAV1) promotes cancer cell migration, invasion, and metastasis.
- E-cadherin co-expression inhibits CAV1's metastasis-promoting functions, but the mechanism is unclear.
- The interaction between CAV1, E-cadherin, and β-catenin in metastasis regulation requires further elucidation.
Purpose of the Study:
- To identify proteins interacting with CAV1 in the presence of E-cadherin.
- To investigate the role of protein tyrosine phosphatase PTPN14 in CAV1-mediated metastasis.
- To determine if PTPN14 can regulate CAV1 activity and cancer cell behavior.
Main Methods:
- Mass spectrometry to analyze protein complexes involving CAV1.
- Co-immunoprecipitation and Western blotting to confirm protein interactions.
- Functional assays measuring cell migration, invasion, and Rac-1 activation.
- In vivo metastasis assays in a murine melanoma model.
Main Results:
- The protein tyrosine phosphatase PTPN14 was identified in CAV1 immunoprecipitates when E-cadherin was co-expressed.
- PTPN14 directly interacts with CAV1, and this interaction is independent of E-cadherin for the CAV1(Y14F) mutant.
- Overexpression of PTPN14 reduced CAV1 phosphorylation, suppressed CAV1-enhanced cell migration, invasion, and Rac-1 activation, and inhibited metastasis in vivo.
Conclusions:
- CAV1 is a novel substrate for the protein tyrosine phosphatase PTPN14.
- PTPN14 negatively regulates CAV1 activity and suppresses its pro-metastatic functions.
- PTPN14 overexpression is sufficient to reduce CAV1-induced metastasis, highlighting its therapeutic potential.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
MAPK Signaling Cascades
Receptor Tyrosine Kinases
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Amplifying Signals via Enzymatic Cascade


